Cover Image
Market Research Report

North America Protein Sequencing Market Forecast 2020-2028

Published by Inkwood Research Product code 928601
Published Content info 93 Pages
Delivery time: 2-3 business days
Price
Back to Top
North America Protein Sequencing Market Forecast 2020-2028
Published: March 16, 2020 Content info: 93 Pages
Description

KEY FINDINGS

The protein sequencing market of North America is evaluated to grow at a CAGR of 5.66% during the estimated period of 2020-2028. The rise in the availability, and accessibility of protein sequencing, and well-established healthcare infrastructure is one of the essential factors driving market growth in the region.

MARKET INSIGHTS

The North American protein sequencing market is segregated into the countries of the US and Canada for further analysis. The Canadian biotechnology industry is expected to grow considerably in the next five years. Government programs play a significant role in obtaining commercial success and product development. The SR&ED was the most accessed program, with 72% of the respondents benefitting from it. The second position was acquired by IRAP, with 58% of respondents, followed by provincially funded programs with 33%. The Canadian biotechnology industry is heavily concentrated in three provinces, Quebec, Ontario, and British Columbia, which account for 75% of all the biotech companies in the country. Quebec has 146 companies, Ontario 129, and British Columbia 91. As far as research and development are concerned, Quebec is the leading province with 33% of Canadian R&D expenditure, followed by Ontario at 31%, and finally, British Columbia with 25%. These three leading jurisdictions have prospered around four cities, Montreal, Ottawa, Toronto, and Vancouver, that could be considered as serious competitors to the status of clusters. Biologics carry on to dominate market share and is an extraordinary driver of market growth. Patent expiry triggering colossal revenue losses for brand products and expansion of the generic sector is in disparity with innovation in biologics.

COMPETITIVE INSIGHTS

Agilent Technologies Inc, Charles River Laboratories Inc, Thermo Fisher Scientific Inc, Bruker Corporation, Bioinformatics Solutions Inc, etc. are some of the renowned companies operating in the region.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation cater to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of Contents
Product Code: 30230

Table of contents

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. GROWING FOCUS ON TARGET-BASED DRUG DEVELOPMENT
    • 3.2.2. DEVELOPMENTS IN MASS SPECTROMETRY AND ANALYTICAL TECHNIQUES
    • 3.2.3. ADVANCES IN COMPUTATIONAL PROTEOMICS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. SHORTAGE OF TRAINED RESEARCHERS AND LABORATORY PROFESSIONALS
    • 3.3.2. EXORBITANT COST LEVIED BY INFRASTRUCTURE

4. KEY ANALYTICS

  • 4.1. KEY INVESTMENT INSIGHTS
  • 4.2. PORTER'S FIVE FORCE ANALYSIS
    • 4.2.1. BUYER POWER
    • 4.2.2. SUPPLIER POWER
    • 4.2.3. SUBSTITUTION
    • 4.2.4. NEW ENTRANTS
    • 4.2.5. INDUSTRY RIVALRY
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE

5. MARKET BY PRODUCT AND SERVICE

  • 5.1. REAGENTS AND CONSUMABLES
  • 5.2. INSTRUMENTS
    • 5.2.1. EDMAN DEGRADATION
    • 5.2.2. MASS SPECTROMETRY
  • 5.3. ANALYSIS PRODUCT
  • 5.4. PROTEIN SEQUENCING SERVICES

6. MARKET BY TECHNOLOGY

  • 6.1. MASS SPECTROMETRY
  • 6.2. EDMAN DEGRADATION

7. MARKET BY APPLICATION

  • 7.1. ACADEMIA
  • 7.2. BIOPHARMACEUTICALS
  • 7.3. BIOTECHNOLOGY RESEARCH

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. UNITED STATES
    • 8.1.2. CANADA

9. COMPANY PROFILES

  • 9.1. SHIMADZU CORPORATION
  • 9.2. AGILENT TECHNOLOGIES INC
  • 9.3. THERMOFISHER SCIENTIFIC INC
  • 9.4. PROTEOME FACTORY
  • 9.5. WATER CORPORATION
  • 9.6. BIOINFORMATICS SOLUTION
  • 9.7. CHARLES RIVER LABORATORIES INC
  • 9.8. SELVITA
  • 9.9. RAPID NOVOR
  • 9.10. SGS SA
  • 9.11. BRUKER CORPORATION
  • 9.12. TAKARA BIO INC

List of Tables

  • TABLE 1: MARKET SNAPSHOT - PROTEIN SEQUENCING
  • TABLE 2: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY PRODUCT AND SERVICE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY PRODUCT AND SERVICE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 4: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY INSTRUMENTS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY INSTRUMENTS, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 6: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 8: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY APPLICATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 10: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 11: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)

List of Figures

  • FIGURE 1: KEY INVESTMENT INSIGHTS
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: NORTH AMERICA PROTEIN SEQUENCING MARKET, GROWTH POTENTIAL, BY PRODUCT AND SERVICE, IN 2019
  • FIGURE 6: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY REAGENTS AND CONSUMABLES, 2020-2028 (IN $ MILLION)
  • FIGURE 7: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY INSTRUMENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 8: NORTH AMERICA PROTEIN SEQUENCING MARKET, GROWTH POTENTIAL, BY INSTRUMENTS, IN 2019
  • FIGURE 9: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY EDMAN DEGRADATION, 2020-2028 (IN $ MILLION)
  • FIGURE 10: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY MASS SPECTROMETRY, 2020-2028 (IN $ MILLION)
  • FIGURE 11: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY ANALYSIS PRODUCT, 2020-2028 (IN $ MILLION)
  • FIGURE 12: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY PROTEIN SEQUENCING SERVICES, 2020-2028 (IN $ MILLION)
  • FIGURE 13: NORTH AMERICA PROTEIN SEQUENCING MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2019
  • FIGURE 14: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY MASS SPECTROMETRY, 2020-2028 (IN $ MILLION)
  • FIGURE 15: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY EDMAN DEGRADATION, 2020-2028 (IN $ MILLION)
  • FIGURE 16: NORTH AMERICA PROTEIN SEQUENCING MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2019
  • FIGURE 17: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY ACADEMIA, 2020-2028 (IN $ MILLION)
  • FIGURE 18: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY BIOPHARMACEUTICALS, 2020-2028 (IN $ MILLION)
  • FIGURE 19: NORTH AMERICA PROTEIN SEQUENCING MARKET, BIOTECHNOLOGY, 2020-2028 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA PROTEIN SEQUENCING MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 21: UNITED STATES PROTEIN SEQUENCING MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 22: CANADA PROTEIN SEQUENCING MARKET, 2020-2028 (IN $ MILLION)
Back to Top